Search Within

Sergio Andres Giralt

Formats
  1. Meeting Abstract (642)
  2. Journal Article (376)
  3. Research Letter (20)
  4. Review (15)
  5. Guidelines (5)
  6. Correspondence (4)
  7. Editorial (4)
  8. Book Section (3)
Groups
  1. Bone Marrow Transplant (1069)
  2. Center for Hematologic Malignancies (1069)
  3. Department of Medicine (1069)
  4. Hematologic Malignancies, Division of (1069)
  5. Survivorship Research (703)
  6. CTCR Scholars (557)

More Groups

People
  1. Miguel-Angel Perales (429)
  2. Sean Devlin (380)
  3. Gunjan Shah (311)
  4. Michael Scordo (279)
  5. Heather Landau (263)
  6. Ann Jakubowski (242)

More People

Years
  1. 2025 (18)
  2. 2024 (65)
  3. 2023 (104)
  4. 2022 (77)
  5. 2021 (66)
  6. 2020 (91)

More Years

Publications
  1. Blood (314)
  2. Biology of Blood and Marrow Transplantation (275)
  3. Bone Marrow Transplantation (80)
  4. Clinical Lymphoma, Myeloma and Leukemia (60)
  5. Journal of Clinical Oncology (40)
  6. Transplantation and Cellular Therapy (36)

More Publications

Publishers
  1. Elsevier Inc. (386)
  2. American Society of Hematology (349)
  3. Nature Publishing Group (110)
  4. American Society of Clinical Oncology (42)
  5. Taylor & Francis Group (35)
  6. Ferrata Storti Foundation (13)

More Publishers

Results (1069)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pharmacokinetics and toxicities after Evomela® (propylene glycol free melphalan) with autologous hematopoietic stem cell transplant (AHCT) for multiple myeloma and AL amyloidosis
    Meeting Abstract

    Shah, G. L.; Landau, H.; Sarubbi, C.; Schofield, R.; Lin, A.; Bhatt, V.; Harnicar, S. J.; Devlin, S. M.; Chung, D. J.; Dahi, P. B.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Patients with central nervous system lymphoma undergoing thiotepa, busulfan, and cyclophosphamide-conditioned autologous stem cell transplantation are at a higher risk for DNA virus infections than patients with systemic non-Hodgkin lymphoma receiving traditional conditioning
    Meeting Abstract

    Scordo, M.; Morjaria, S. M.; Bhatia, A.; Littmann, E. R.; Maloy, M.; DeAngelis, L.; Giralt, S. A.; Taur, Y.; Sauter, C. S.
    Blood (2017)

    Fulltext@MSK | Save
  • Adults receiving defibrotide for the treatment of hepatic veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS) after hematopoietic stem cell transplantation (HSCT): Final results from the expanded-access program
    Meeting Abstract

    Richardson, P. G.; Antin, J. H.; Giralt, S. A.; Ryan, R. J.; Liang, W.; Hume, R. L.; Tappe, W. M.; Kernan, N. A.
    Blood (2017)

    Fulltext@MSK | Save
  • Adoptive T-cell therapy with 3rd party CMV-pp65-specific CTLs for CMV viremia and disease arising after allogeneic hematopoietic stem cell transplant
    Meeting Abstract

    Prockop, S.; Doubrovina, E.; Rodriguez-Sanchez, I.; Hasan, A. N.; Barker, J.; Castro-Malaspina, H. R.; Dahi, P. B.; Giralt, S. A.; Gyurkocza, B.; Kernan, N. A.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Intestinal microbiota injury during allo-HSCT is generalizable across transplantation centers and is associated with increased mortality, broad-spectrum antibiotics, and decreased calorie intake
    Meeting Abstract

    Peled, J. U.; Gomes, A.; Buchan, M. L.; Stein-Thoeringer, C. K.; Slingerland, J. B.; Slingerland, A. E.; Weber, D.; Sung, A. D.; Maloy, M.; Peets, T.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Long-term follow-up of adult double unit cord blood (CB) transplantation (dCBT) recipients reveals high rates of progression-free survival after a novel cy/flu/thio/TBI 400 intermediate intensity conditioning regimen
    Meeting Abstract

    Politikos, I.; Devlin, S. M.; Jacob, A.; Maloy, M.; Mazis, C.; Naputo, K.; Scaradavou, A.; O'Reilly, R.; Avecilla, S.; Castro-Malaspina, H. R.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • More intensive fludarabine/busulfan (Flu/Bu) conditioning regimens result in similar outcomes without adding serious toxicity when compared to fludarabine/melphalan (Flu/Mel) in patients undergoing allogeneic hematopoietic cell transplant (Allo-HCT)
    Meeting Abstract

    Pappacena, J.; Bhatt, V.; Shah, G. L.; Hilden, P.; Maloy, M.; Buie, L. W.; Giralt, S. A.; Scordo, M.
    Blood (2017)

    Fulltext@MSK | Save
  • Impact of omitting post-transplant mini-methotrexate doses in allogeneic hematopoietic cell transplantation: A single-center retrospective study
    Meeting Abstract

    Lin, A.; Hilden, P.; Maloy, M.; Jakubowski, A. A.; Papadopoulos, E. B.; Sauter, C. S.; Tamari, R.; Ponce, D.; Giralt, S. A.; Gyurkocza, B.
    Blood (2017)

    Fulltext@MSK | Save
  • Costs and in-hospital mortality rates in autologous stem cell transplant for multiple myeloma: An analysis of the Nationwide Inpatient Sample (NIS) Database
    Meeting Abstract

    Liu, Y.; Han, H.; Wei, X.; Wang, Q.; He, J.; Shah, G. L.; Giralt, S. A.; Landgren, O.; Lesokhin, A.
    Blood (2017)

    Fulltext@MSK | Save
  • Ex vivo T cell-depleted and in vivo T cell-depleted allogeneic stem cell transplantation in patients with acute myeloid leukemia in first complete remission resulted in similar overall survival survival: On behalf of the ALWP of the EBMT and the MSKCC
    Meeting Abstract

    Malard, F.; Labopin, M.; Cho, C.; Blaise, D.; Papadopoulos, E. B.; Passweg, J. R.; O'Reilly, R.; Milpied, N.; Maloy, M.; Volin, L.; more...
    Blood (2017)

    Fulltext@MSK | Save